Validation of the CNS penetration-effectiveness rank for quantifying antiretroviral penetration into the central nervous system S Letendre, J Marquie-Beck, E Capparelli, B Best, D Clifford, AC Collier, ... Archives of neurology 65 (1), 65-70, 2008 | 1011 | 2008 |
Recognition of a Kawasaki disease shock syndrome JT Kanegaye, MS Wilder, D Molkara, JR Frazer, J Pancheri, AH Tremoulet, ... Pediatrics 123 (5), e783-e789, 2009 | 489 | 2009 |
Resistance to intravenous immunoglobulin in children with Kawasaki disease AH Tremoulet, BM Best, S Song, S Wang, E Corinaldesi, JR Eichenfield, ... The Journal of pediatrics 153 (1), 117-121. e3, 2008 | 445 | 2008 |
Greater tenofovir-associated renal function decline with protease inhibitor-based versus nonnucleoside reverse-transcriptase inhibitor-based therapy M Goicoechea, S Liu, B Best, S Sun, S Jain, C Kemper, M Witt, ... The Journal of infectious diseases 197 (1), 102-108, 2008 | 370 | 2008 |
Infliximab treatment of intravenous immunoglobulin–resistant Kawasaki disease JC Burns, BM Best, A Mejias, L Mahony, DE Fixler, HS Jafri, ME Melish, ... The Journal of pediatrics 153 (6), 833-838. e6, 2008 | 335 | 2008 |
Reduced lopinavir exposure during pregnancy AM Stek, M Mirochnick, E Capparelli, BM Best, C Hu, SK Burchett, C Elgie, ... Aids 20 (15), 1931-1939, 2006 | 206 | 2006 |
Marijuana use by breastfeeding mothers and cannabinoid concentrations in breast milk KA Bertrand, NJ Hanan, G Honerkamp-Smith, BM Best, CD Chambers Pediatrics 142 (3), 2018 | 170 | 2018 |
Randomized trial of central nervous system–targeted antiretrovirals for HIV-associated neurocognitive disorder RJ Ellis, S Letendre, F Vaida, R Haubrich, RK Heaton, N Sacktor, ... Clinical Infectious Diseases 58 (7), 1015-1022, 2014 | 157 | 2014 |
Low atazanavir concentrations in cerebrospinal fluid BM Best, SL Letendre, E Brigid, DB Clifford, AC Collier, BB Gelman, ... Aids 23 (1), 83-87, 2009 | 148 | 2009 |
Pharmacokinetics of lopinavir/ritonavir crushed versus whole tablets in children BM Best, EV Capparelli, H Diep, SS Rossi, MJ Farrell, E Williams, G Lee, ... JAIDS Journal of Acquired Immune Deficiency Syndromes 58 (4), 385-391, 2011 | 130 | 2011 |
Efficacy and safety of dolutegravir with emtricitabine and tenofovir alafenamide fumarate or tenofovir disoproxil fumarate, and efavirenz, emtricitabine, and tenofovir … S Lockman, SS Brummel, L Ziemba, L Stranix-Chibanda, K McCarthy, ... The Lancet 397 (10281), 1276-1292, 2021 | 121 | 2021 |
Antiretroviral therapy adherence, medication use, and health care costs during 3 years of a community pharmacy medication therapy management program for Medi-Cal beneficiaries … JD Hirsch, M Gonzales, A Rosenquist, TA Miller, TP Gilmer, BM Best Journal of Managed Care Pharmacy 17 (3), 213-223, 2011 | 118 | 2011 |
Exclusion of pregnant women from clinical trials during the coronavirus disease 2019 pandemic: a review of international registries DD Smith, JL Pippen, AA Adesomo, KM Rood, MB Landon, ... American journal of perinatology 37 (08), 792-799, 2020 | 116 | 2020 |
Transcript abundance patterns in Kawasaki disease patients with intravenous immunoglobulin resistance W Fury, AH Tremoulet, VE Watson, BM Best, C Shimizu, J Hamilton, ... Human immunology 71 (9), 865-873, 2010 | 111 | 2010 |
Efavirenz concentrations in CSF exceed IC50 for wild-type HIV BM Best, PP Koopmans, SL Letendre, EV Capparelli, SS Rossi, ... Journal of Antimicrobial Chemotherapy 66 (2), 354-357, 2011 | 107 | 2011 |
Efavirenz pharmacokinetics during the third trimester of pregnancy and postpartum TR Cressey, A Stek, E Capparelli, C Bowonwatanuwong, S Prommas, ... JAIDS Journal of Acquired Immune Deficiency Syndromes 59 (3), 245-252, 2012 | 106 | 2012 |
Atazanavir pharmacokinetics with and without tenofovir during pregnancy M Mirochnick, BM Best, AM Stek, EV Capparelli, C Hu, SK Burchett, ... JAIDS Journal of Acquired Immune Deficiency Syndromes 56 (5), 412-419, 2011 | 100 | 2011 |
Low cerebrospinal fluid concentrations of the nucleotide HIV reverse transcriptase inhibitor, tenofovir BM Best, SL Letendre, P Koopmans, SS Rossi, DB Clifford, AC Collier, ... JAIDS Journal of Acquired Immune Deficiency Syndromes 59 (4), 376-381, 2012 | 99 | 2012 |
Lopinavir tablet pharmacokinetics with an increased dose during pregnancy BM Best, AM Stek, M Mirochnick, C Hu, H Li, SK Burchett, SS Rossi, ... JAIDS Journal of Acquired Immune Deficiency Syndromes 54 (4), 381-388, 2010 | 99 | 2010 |
Evaluation of the first year of a pilot program in community pharmacy: HIV/AIDS medication therapy management for Medi-Cal beneficiaries JD Hirsch, A Rosenquist, BM Best, TA Miller, TP Gilmer Journal of Managed Care Pharmacy 15 (1), 32-41, 2009 | 96 | 2009 |